Holen Sie sich die Stockscreener-App
431.87
11.56%
44.75
Handel nachbörslich:
438.49
6.62
+1.53%
Schlusskurs vom Vortag:
$387.12
Offen:
$450.49
24-Stunden-Volumen:
4.99M
Relative Volume:
2.60
Marktkapitalisierung:
$51.86B
Einnahmen:
$137.20B
Nettoeinkommen (Verlust:
$1.15B
KGV:
46.22
EPS:
9.3439
Netto-Cashflow:
$1.27B
1W Leistung:
+11.20%
1M Leistung:
+7.96%
6M Leistung:
+118.87%
1J Leistung:
+48.61%
1-Tages-Spanne:
$428.45
$456.50
1-Wochen-Bereich:
$375.86
$456.50
52-Wochen-Spanne:
$163.11
$456.50
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
431.87 | 51.86B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
379.30 | 340.46B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
86.16 | 110.20B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
412.70 | 89.50B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.43 | 74.63B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-07 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2026-09-25 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-08-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2026-07-30 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2026-07-30 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2026-07-30 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-07-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-07-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-05-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research
Humana Inc. (HUM) Stock Forecasts - Yahoo Finance
Humana Inc. (HUM) Stock Forecasts - Yahoo Finance
8,526 Shares of Humana Inc. $HUM Purchased by Vista Investment Partners LLC - MarketBeat
UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research
Humana Inc. Advanced Charts | HUM - Barron's
Report highlights Humana’s $13B impact in Louisville - The Business Journals
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Humana upgraded at Cantor on Medicare margin and STARS recovery - Seeking Alpha
Humana (NYSE:HUM) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - TradingView
Humana Inc. Research & Ratings | HUM - Barron's
Humana generated $20 billion in Ky. economic activity in 2025, report says - Kentucky Today
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research
Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds - Yahoo Finance
Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds - Humana
Humana Inc. Advanced Charts | HUM - Barron's
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $380.50 vs Price $404.07 - GuruFocus
Humana, HHS, Spar Over Medicare Advantage Payments in Court - Bloomberg Law News
Humana, HHS, Spar Over Medicare Advantage Payments in Court - Bloomberg Law News
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure - TradingView
Humana Inc. Research & Ratings | HUM - Barron's
Humana Inc. (HUM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Humana Inc. (HUM) stock price, news, quote and history - Yahoo Finance UK
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
UnitedHealth and Humana cutting Medicare Advantage plans in 2027 - Yahoo Finance
Form 4 Humana Inc For: 2 October By Investing.com - Investing.com Canada
A director acquires 238 stock units at Humana (HUM) by converting a cash fee. - Stock Titan
Humana shrinks Medicare Advantage footprint (HUM:NYSE) - Seeking Alpha
Health Insurers Ditch Medicare Advantage Plans to Boost Profit - Bloomberg.com
Some 2027 Medicare plans add $0 in-network lab tests through Humana - Stock Titan
Zacks Research Has Optimistic Opinion of Humana Q3 Earnings - MarketBeat
Envestnet Asset Management Inc. Increases Position in Humana Inc. $HUM - MarketBeat
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
Announcing the Winners of the 2026 TrustMaker Awards by OneTrust - GlobeNewswire Inc.
Humana Inc Lobbying Profile, 2011 - OpenSecrets
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Humana Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Humana (HUM) Stock Is Up Today - Yahoo Finance
Humana Jumps 7.9% After Barclays Upgrades to Overweight - AlphaStreet
Humana Inc (HUM) Shares Surge 4.6% -- What GF Score of 87 Tells Investors - GuruFocus
Form 4 Humana Inc For: 25 September By Investing.com - Investing.com Nigeria
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana surges: Barclays bets big on Medicare star ratings rebound - Yahoo Finance
Why Humana (HUM) Stock Is Up Today - Quiver Quantitative
Humana Inc Stock (HUM) Moved Up by 7.74% on Sep 25: A Full Analysis - TradingKey
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient - GlobeNewswire Inc.
Form 4 Humana Inc For: 25 September By Investing.com - Investing.com Canada
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Humana Inc-Aktie (HUM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):